UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions

The Journal of clinical investigation, 2023-06, Vol.133 (12), p.1-17

2023

Link zum Volltext

Verfügbarkeit prüfen

HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation

PloS one, 2013-08, Vol.8 (8), p.e71228-e71228

2013

Link zum Volltext

Verfügbarkeit prüfen

Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer

Cell, 2020-04, Vol.181 (2), p.442-459.e29

2020

Link zum Volltext

Verfügbarkeit prüfen

Determinants of immunodominance for CD4 T cells

Current opinion in immunology, 2015-06, Vol.34, p.9-15

2015

Link zum Volltext

Verfügbarkeit prüfen

Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection

Immunologic research, 2010-07, Vol.47 (1-3), p.56-64

2010

Link zum Volltext

Verfügbarkeit prüfen

Selection of immunodominant epitopes during antigen processing is hierarchical

Molecular immunology, 2019-09, Vol.113, p.115-119

2019

Link zum Volltext

Verfügbarkeit prüfen

Exogenous antigens bind MHC class II first, and are processed by cathepsins later

Molecular immunology, 2015-12, Vol.68 (2), p.81-84

2015

Link zum Volltext

Verfügbarkeit prüfen

LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8 + T Cells

The Journal of immunology (1950), 2019-08, Vol.203 (4), p.1076-1087

2019

Link zum Volltext

Verfügbarkeit prüfen

MHC Class II Auto-Antigen Presentation is Unconventional

Frontiers in immunology, 2015-07, Vol.6, p.372-372

2015

Link zum Volltext

Verfügbarkeit prüfen

Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources

Nature communications, 2014-11, Vol.5 (1), p.5369-5369, Article 5369

2014

Link zum Volltext

Verfügbarkeit prüfen

A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design

The Journal of experimental medicine, 2023-07, Vol.220 (7)

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction: LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8 + T Cells

The Journal of immunology (1950), 2019-10, Vol.203 (7), p.2023-2024

2019

Link zum Volltext

Verfügbarkeit prüfen

Distorted Immunodominance by Linker Sequences or other Epitopes from a Second Protein Antigen During Antigen-Processing

Scientific reports, 2017-04, Vol.7 (1), p.46418-46418, Article 46418

2017

Link zum Volltext

Verfügbarkeit prüfen

Exploring a possible role for the MHC Class II accessory molecule H2-O in the development of experimental autoimmune encephalomyelitis

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.46-46.10

2016

Link zum Volltext

Verfügbarkeit prüfen

HLA-DO and its effect on peptide binding to MHC Class II (106.29)

The Journal of immunology (1950), 2012-05, Vol.188 (1_Supplement), p.106-106.29

2012

Link zum Volltext

Verfügbarkeit prüfen

Studying MHC Class II Peptide Loading and Editing In Vitro

Methods in molecular biology (Clifton, N.J.), 2019-01, Vol.1988, p.343

2019

Link zum Volltext

Verfügbarkeit prüfen

Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis

Journal of proteome research, 2017-01, Vol.16 (1), p.355-365

2017

Link zum Volltext

Verfügbarkeit prüfen

HLA-DO and Its Role in MHC Class II Antigen Presentation

Frontiers in immunology, 2013-01, Vol.4, p.260-260

2013

Link zum Volltext

Verfügbarkeit prüfen

Oscarellin, an Anthranilic Acid Derivative from a Philippine Sponge, Oscarella stillans, as an Inhibitor of Inflammatory Cytokines in Macrophages

Journal of natural products (Washington, D.C.), 2017-01, Vol.80 (1), p.149-155

2017

Link zum Volltext

Verfügbarkeit prüfen

Understanding how HLA-DO works

Molecular immunology, 2012-05, Vol.51 (1), p.29-29

2012

Link zum Volltext

Verfügbarkeit prüfen

Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins In Vivo

Angewandte Chemie (International ed.), 2013-07, Vol.52 (27), p.6880-6884

2013

Link zum Volltext

Verfügbarkeit prüfen

Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins InVivo

Angewandte Chemie (International ed.), 2013-07, Vol.52 (27), p.6880-6884

International ed. in English, 2013

Link zum Volltext

Verfügbarkeit prüfen

HLA-DM targets the hydrogen bond between the histidine at position β81 and peptide to dissociate HLA-DR -peptide complexes

Nature immunology, 2007-01, Vol.8 (1), p.92-100

2007

Link zum Volltext

Verfügbarkeit prüfen

A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes

Nature medicine, 2010-11, Vol.16 (11), p.1333-1340

2010

Link zum Volltext

Verfügbarkeit prüfen

Multiple paths to immunodominance: dominant epitopes are captured by MHC II prior, or post antigen proteolysis, and are enriched by HLA-DM (APP2P.103)

The Journal of immunology (1950), 2014-05, Vol.192 (1_Supplement), p.43-43.4

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(42)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions

HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation

Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer

Determinants of immunodominance for CD4 T cells

Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection

Selection of immunodominant epitopes during antigen processing is hierarchical

Exogenous antigens bind MHC class II first, and are processed by cathepsins later

LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8 + T Cells

MHC Class II Auto-Antigen Presentation is Unconventional

Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources

A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design

Correction: LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8 + T Cells

Distorted Immunodominance by Linker Sequences or other Epitopes from a Second Protein Antigen During Antigen-Processing

Exploring a possible role for the MHC Class II accessory molecule H2-O in the development of experimental autoimmune encephalomyelitis

HLA-DO and its effect on peptide binding to MHC Class II (106.29)

Studying MHC Class II Peptide Loading and Editing In Vitro

Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis

HLA-DO and Its Role in MHC Class II Antigen Presentation

Oscarellin, an Anthranilic Acid Derivative from a Philippine Sponge, Oscarella stillans, as an Inhibitor of Inflammatory Cytokines in Macrophages

Understanding how HLA-DO works

Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins In Vivo

Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins InVivo

HLA-DM targets the hydrogen bond between the histidine at position β81 and peptide to dissociate HLA-DR -peptide complexes

A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes

Multiple paths to immunodominance: dominant epitopes are captured by MHC II prior, or post antigen proteolysis, and are enriched by HLA-DM (APP2P.103)

Suchergebnisse filtern